In our case, tumour cells showed weak to moderate but diffuse staining with anti-PDL1 antibody (TPS score > 90% and CPS at 95) (Fig. 3F), which could allow future anti-PD1 treatment in case of recurrence. Here, CD274 is linked to neoplasm.